ライフサイエンスコーパス: each group

1 ose with PVR-A, PVR-B, and PVR-C (n = 10 for each group).

2 ht or 50-lux dim red placebo light (N=23 for each group).

3 low or medium dose insulin infusion (n = 10 each group).

4 and 98 with placebo) and 200 deaths (100 in each group).

5 PE, GDM, or uncomplicated pregnancy (n = 10 each group).

6 ctively), and headache (17 [15%] patients in each group).

7 A total of 54 children were recruited (27 in each group).

8 naprevir) and headache (one [17%] patient in each group).

9 nal features and healthy subjects (n = 26 in each group).

10 ebo group) and thrombocytopenia (43 [15%] in each group).

11 ion with bendamustine plus rituximab (289 in each group).

12 ere matched 1:1 in the two groups (67,328 in each group).

13 ol subjects and patients with ILD (n = 42 in each group).

14 r score between the groups (P < .001 between each group).

15 onary toxicities was similar (one patient in each group).

16 ning of the breeding period (n = 12 pairs in each group).

17 ion group or the control group (916 women in each group).

18 collagen served as control animals (four in each group).

19 included 282/300 (94%) children (n = 141 in each group).

20 ced by 24% or 35% carob pulp (n = 9 lambs in each group).

21 and VRC 320 enrolled 45 participants (15 in each group).

22 ents underwent randomization (98 patients in each group).

23 pt 28, 2012, we enrolled 124 patients (62 in each group).

24 had undergone randomization (35 patients in each group).

25 olunteers (aged 22-56 years, nine females in each group).

26 t least one dose of study medication (181 in each group).

27 notification or study procedures occurred in each group).

28 in the intention-to-treat population (64 in each group).

29 c data were obtained from 66 patients (33 in each group).

30 ere all frozen shoulders (in two patients in each group).

31 tory tract infections (five [5%] patients in each group).

32 cebo group), and myalgia (one [2%] person in each group).

33 s increased in both ApoE groups (P = 0.03 in each groups).

34 red pathways of cytotoxic response shared by each group.

35 Eight serious adverse events occurred in each group.

36 identified in at least 80% of individuals in each group.

37 eaths occurred, but 1 graft loss occurred in each group.

38 s of hippocampal volume assessed with MRI in each group.

39 10) viral particles--with 20 participants in each group.

40 adverse events occurred in four patients in each group.

41 f UTIs caused by E coli vaccine serotypes in each group.

42 evere sepsis with equal number of animals in each group.

43 Three deaths (1%) occurred in each group.

44 and HBV-specific T cells were quantified for each group.

45 ange in anthropometric z scores were fit for each group.

46 onomic groups, quantifying the change within each group.

47 etermine specific Raman spectral features of each group.

48 ween species, with unique network anchors in each group.

49 method is developed to select a feature from each group.

50 ms, KEGG pathways and SMART/Pfam domains for each group.

51 ficant changes 1 year postoperatively within each group.

52 he body mass scaling of oxygen diffusion for each group.

53 hree transient ischaemic attacks occurred in each group.

54 T-gr, the most common clinical pathotypes in each group.

55 proximately 90 ms prior to movement onset in each group.

56 33 participants were randomly assigned to each group.

57 Five (2%) patients died during treatment in each group.

58 Propensity matching produced 46 patients in each group.

59 Forty-nine participants were randomized to each group.

60 0 patients with SCD were studied, with 90 in each group.

61 ons and exhibit distinct sequence changes in each group.

62 ts, of whom we enrolled 120: 60 allocated to each group.

63 t each visit through 3 years were similar in each group.

64 Baseline HbA1c was 8.8% in each group.

65 Two patients died due to toxicity, one in each group.

66 al of 36 patients were recruited, with 18 in each group.

67 closan group or patients without diabetes in each group.

68 Eighty-eight patients were included, 44 in each group.

69 ous adverse events were reported, 17 (5%) in each group.

70 lycemia events occurred in 2 participants in each group.

71 radiographically in the mandible samples of each group.

72 s, with 1 superfificial venous thrombosis in each group.

73 Nine to 13 vessels were used in each group.

74 y experts (N = 12) with representatives from each group.

75 ) were enrolled, and 112 were randomized for each group.

76 and only 1 case of femoral shaft fracture in each group.

77 remaining free of encephalopathy was 65% for each group.

78 We enrolled 680 patients in each group.

79 o was compared among different visits within each group.

80 by contrast sensitivity and glare tests for each group.

81 tients revealed improvement in 4 patients in each group.

82 and equal probabilities of being assigned to each group.

83 matching analysis extracted 63 patients from each group.

84 une 16 and Oct 10, 2015, and analysed 835 in each group.

85 svir, and asunaprevir) until six patients in each group (1:1:1) achieved an ultrarapid virological re

86 re success), including 31 redo procedures in each group (19.5% of RF versus 19.9% of CB; P=0.933).

87 affected around a quarter of the patients in each group (20 [24%] and nine [25%], respectively).

88 Adverse event profiles were similar in each group: 224 (57%) of 392 patients in the afatinib gr

89 sions of patients who did not undergo PCI in each group (337 in the PCI and thrombectomy group and 33

90 fant deaths at age 0-6 months was similar in each group (50 in the placebo group and 61 in the vaccin

91 1500 study participants (750 randomized for each group), 731 in iron group and 738 in placebo group

92 determinate, 1 was found to be metastatic in each group (8% and 6%, respectively).

93 ys was low (4%) and occurred in 1 patient in each group (95% CI, 0.06 to 16.93; P > .99).

94 r reverse remodeling (hazard ratio: 0.66 per each group; 95% CI: 0.50 to 0.85; p = 0.002).

95 mean reduction in Hb at day 7 was similar in each group, a difference in the ACT + PQ versus the ACT

96 e to refractory intracranial hypertension in each group (abusive head trauma, 66.7% vs nonabusive hea

97 Six patients in each group achieved an ultrarapid virological response (

98 Each group activated the fronto-parietal WM networks and

99 In each group, acute limb ischemia occurred in 1.7% of the

100 each group) and large sample sizes (n=24 in each group), all methods compared had similar power, exc

101 Clinical characteristics and risk factors in each group also were compared.

102 Four clusters were randomised to each group and 799 patients per group analysed.

103 Three serious adverse events occurred in each group and none were treatment related; two resulted

104 or early termination visit was determined in each group and statistically compared using analysis of

105 for the largest share of the total costs in each group and was also lower in the intervention group

106 For medium (n=12 in each group) and large sample sizes (n=24 in each group),

107 ue procedure for samples of large size(30 in each group) and medium size (15 in each group) for eithe

108 The overall incidence (34 [83%] of 41 in each group) and severity of adverse events (two [5%] of

109 atment groups (8 groups total, n = 3 to 6 in each group) and treated for 1 week.

110 were nasopharyngitis (eight [8%] patients in each group) and upper respiratory tract infections (five

111 nine to idarucizumab and three to placebo in each group), and 11 were enrolled into the 4 g idarucizu

112 the GDM and non-diabetic subjects (n = 6 for each group), and the platelets and trophoblasts were iso

113 VRC 319 enrolled 80 participants (20 in each group), and VRC 320 enrolled 45 participants (15 in

114 patients) and vomiting (ten [2%] patients in each group); and nervous system disorders, including hea

115 ere within the normal range, were similar in each group, and did not change over time.

116 There were 64 men (49.6%) in each group, and most patients were white (119 [92.2%], 1

117 rategy, the consensus RNA-binding pockets in each group are identified.

118 dies including a larger number of samples in each group are needed in order to validate these finding

119 limbing phenotypes were classified; lines in each group are reported.

120 Representative bioelectronic systems for each group are summarized based on various stages of a c

121 Infarct size and LV mass decreased >/=30% in each group at 6 months and declined gradually to 2 years

122 yses were performed in nerves harvested from each group at different survival times.

123 y score matching, 3,841 patients remained in each group (bankruptcy v no bankruptcy).

124 e the region-specific divergence in CNVR for each group based on unbiased estimates of pairwise V ST

125 For small sample size (n=3 or 6 in each group), both the empirical Bayes and bump hunting m

126 different prior beliefs about reversals that each group brings to the task.

127 There were two patient deaths (one in each group), but these were not deemed to be related to

128 Three new cases of allergy developed in each group, but after 12 months of avoidance there was n

129 re were similar numbers of adverse events in each group, but patients in the terlipressin group had m

130 omes from worse outcomes equally well within each group, but tended to be over-optimistic when predic

131 symptomatic patients (nine of 17 patients in each group) by reader 2, without significant differences

132 an in-depth understanding of malaria risk in each group challenges further progress towards eliminati

133 However, classification of patients in each group changed markedly after 24 hours of usual care

134 intention-to-treat population (178 [77%] in each group completed 26 weeks of treatment).

135 82 participants were enrolled, and 41 in each group comprised the ITT population; 33 participants

136 d for PDA and 666 were not; 605 infants from each group could be paired.

137 loid formation in pancreas in 5 of 7 mice in each group, demonstrating that IAPP amyloid could be enh

138 acute kidney injury (1.6%) were identical in each group despite longer procedure time and use of more

139 Five patients in each group developed a second infection during hospitali

140 nt developed liver toxicity; two patients in each group developed brain oedema requiring osmotherapy.

141 hypotonic group developed hyponatremia, 1 in each group developed hypernatremia, 2 in each group deve

142 in each group developed hypernatremia, 2 in each group developed hypertension, and 2 in the isotonic

143 Two patients in each group developed serious adverse events: not transpl

144 About 25% of the patients in each group deviated from the assigned therapy, mainly be

145 Three patients in each group did not complete any PRO instruments at any t

146 Of these patients, one in each group did not complete any PRO instruments before w

147 One patient in each group died during the study.

148 Equal numbers in each group died of ischemic heart disease.

149 At week 24, 22 (5%) participants from each group died or were of unknown status (95% CI 3.5-7.

150 Three participants in each group died, all from HIV-related causes.

151 Four patients (2 in each group) died within the first 30 postoperative days.

152 Ten (6%) patients in each group discontinued treatment due to drug-related ad

153 Two practices (one in each group) discontinued because of insufficient resourc

154 One atypical femoral fracture occurred in each group during the extension.

155 ing the incision and those who did not (2 in each group) during follow-up.

156 The organs and tissues in each group either work together to form organ systems or

157 layed HIV assisted partner services (nine in each group), enrolling 1305 625 (48%) in the immediate g

158 layed HIV assisted partner services (nine in each group), enrolling 1305 participants: 625 (48%) in t

159 gned, 598 to PCI and 603 to CABG, and 592 in each group entered analysis by intention to treat.

160 ever, these rhythms were not synchronous, as each group exhibited its own phase of activation.

161 ed to identify 147 well-balanced patients in each group for overall survival comparison.

162 toring after exclusion of four patients from each group for various reasons.

163 Serum level of FGF21 decreased by 50% in each group (for AP diet P < .0002; for PP diet P < .0002

164 ize(30 in each group) and medium size (15 in each group) for either independent, somewhat correlated,

165 te a probability of fitness consequences for each group from associated patterns of genetic polymorph

166 ough increased perfusion was observed within each group from baseline to 6 months (P<0.001).

167 e of 3.0 g per day, or placebo (225 women in each group) from 12 to 18 weeks of gestation until deliv

168 mens were divided into six groups (n = 10 in each group): G1, G3, and G5 (0.5 W, 0.7 W, and 1 W diode

169 The primary efficacy outcome was similar in each group (good outcome in alteplase group 48% vs salin

170 spital acquired pressure injury incidence in each group, group differences and 95% confidence interva

171 For higher degrees of censoring (each group >40% censoring), no technique provided reliab

172 e or in the control group; three patients in each group had >/=50% reduction in level of proteinuria.

173 One patient in each group had a pneumothorax from a CT-guided biopsy sa

174 Similar proportions of patients in each group had a response to therapy, marked by necrosis

175 Similar proportions of patients in each group had adverse events (60/92 [65%] vs 76/109 [70

176 During days 1 to 14, 37% of patients in each group had minor adverse events.

177 d recurrent disease; however, 5/8 animals in each group had subclinical shedding of HSV-2 DNA, on 15/

178 Ninety patients in each group (high-flow nasal oxygen or standard oxygen) w

179 included 3 interface-related skin ulcers for each group (ie, 7.6% in the face mask group had nose ulc

180 Each group improved WMFT performance time relative to ba

181 ned to the respective flight capabilities of each group in relation to the wind currents they travel

182 Each group included 30 patients (30 eyes).

183 Each group included 6 tumors.

184 e entered the number of events and number in each group into RevMan 5.3 and used the Mantel-Haenszel

185 8-10 weeks old were grouped (six animals in each group) into sham surgery (sham group), left anterio

186 gistic regression analysis was conducted for each group.Iron deficiency, malaria, breastfeeding, stun

187 Each group is characterized by a particular chemical rea

188 A final template of themes from each group is presented together with differences outlin

189 d in the overall fat measurements and within each group (low, medium and high fat milk) using the thr

190 For each group (<40 y and >/=40 y), 107 patients were includ

191 n, influenza B/Brisbane/60/2008, were low in each group, making comparisons uninterpretable.

192 an change in HbA1c from baseline was 0.2% in each group (mean difference, 0% [95% CI, -0.3% to 0.3%];

193 42.1 [10.7] vs 43.0 [10.5] years; 30 men in each group; mean [SD] body mass index, 33.7 [5.1] vs 33.

194 two Ala/Thr, five males and four females in each group; median age difference: 1 year; age range: 29

195 Each group member (perceiver) viewed faces of every othe

196 .87); after propensity matching (n = 813 in each group), mortality remained similar (6.3% [95% CI, 4

197 of 400 pg/mL (representing most patients in each group), NT-proBNP had similar predictive value for

198 ding outcome, P value, number of patients in each group, number of events in each group, number of pa

199 patients in each group, number of events in each group, number of patients lost to follow-up, and tr

200 whether a single mouse, chosen randomly from each group of a study, predicted the median response for

201 Yet within each group of fate-changing transcription factors, a sub

202 When each group of measurements is distributed in space, the

203 ll death through flow cytometry detection in each group of patients.

204 us group discussions including neighbours of each group of prototype housing.

205 Each group of related lines converge at a point in a neg

206 of 1.75 for LGA and high infant adiposity in each group of women to identify ethnic-specific criteria

207 In each group, orthotopic kidney transplantation was perfor

208 When sample size is small (5 in each group), our proposed Bon-EV procedure has performan

209 BOP, PD and TC, PD and TG, and CAL and TG in each group (P <0.01).

210 significant difference from baseline within each group (P <0.05), with a difference in clinical and

211 One cardiac death occurred in each group (p=1.00).

212 id-negative urine samples were equal (46% in each group, P=0.91).

213 agnesium group and the placebo group (2.7 in each group, P=1.00).

214 Each group participated in three teaching scenarios, via

215 ch spread between 'hosts' and 'vectors'-with each group possessing distinct epidemiological character

216 ealthy individuals, with six participants in each group, practiced a virtual throwing task for three

217 actorization, we do not assume that users in each group prefer a single group of items.

218 Each group produced a prioritised list of goals, activit

219 Each group proposed updated treatment thresholds, and al

220 2 months (group 2), and 15 months (group 3), each group randomized according to maternal anti-HAV sta

221 n endpoint was the proportion of patients in each group reaching level 1 on the Cerebral Performance

222 After 2 years, subsets in each group received a booster dose.

223 666 patients in each group received at least one dose of study drug at a

224 (1.5x10(6) cells/kg) or placebo; at 90 days, each group received the alternative treatment.

225 Two participants, one from each group, reported persistent erythema, which was cons

226 Each group represents a distinctive pollination mode lin

227 periods of 5 +/- 2.8 y and 4.4 +/- 3.9 y for each group, respectively).

228 curred in 116 (33%) and 58 (17%) patients in each group, respectively.

229 Each group reviewed relevant literature and wrote drafts

230 Second, topological congruence analyses of each group's complete phylogeny and microbiota dendrogra

231 The primary outcome was each group's median surgical supply cost per case.

232 Within each group, samples were divided into 2 subgroups ( n =

233 Within each group, seasonal shifts in community formed cool (sp

234 sion location in the temporal cortex, but in each group, some individuals had additional prefrontal d

235 amination and OCT imaging were performed for each group studied.

236 ow to select one representative feature from each group such that the selected features are jointly d

237 Three deaths occurred in each group that were attributed to DEB-TACE.

238 aid in developing targeted interventions for each group that will reduce the significant morbidity an

239 Of 184 randomized participants (92 to each group), the final analysis included 88 IPLA and 87

240 For low degrees of censoring (<25% in each group), the Generalized Wilcoxon (GW) technique and

241 For each group, the second stage of the trial (enrolment of

242 which categorizes the correlation types for each group to make this possible.

243 s of contents of selected representatives of each group to the sum of all identified markers were pro

244 ently inferred the potential contribution of each group to transmission using a simple model that bui

245 Eight practitioners in each group took part in audio-recorded post-clinic inter

246 Each group underwent both active and sham HD-tDCS in cro

247 ne oil in a deep anterior chamber (3 eyes in each group), untreatable hypotony in 1 eye in the PPV gr

248 tal or nonfatal myocardial infarction) among each group using a 2 x 2 factorial mendelian randomizati

249 e due to screening and diagnostic work-up in each group via mean lead times (MLTs), which were estima

250 or reaching >/=1000 mg of peanut protein) in each group vs placebo patch after 12 months.

251 The mean (SD) age for each group was 58.3 (10.6) years, 56.8 (10.3) years, and

252 Afterward the mean ACE level of each group was calculated and compared.

253 A subset of pigs in each group was challenged orally with 10(5) focus-formin

254 Each group was classified after microbiological investig

255 es, we found that the relative importance of each group was different in different strains and cultur

256 One participant in each group was excluded after randomisation, leaving 412

257 One patient in each group was lost to follow-up.

258 Each group was received either sham therapy or VNS thera

259 Half of each group was simultaneously randomized to receive cogn

260 k factors and perioperative complications in each group were analyzed.

261 pooled estimates for the 5-year mortality in each group were calculated.

262 ncreas graft survival and rejection rates of each group were compared.

263 igs reach market weight, half of the pigs in each group were culled ("market weight" groups).

264 Twenty photograph pairs from each group were duplicated to determine reviewer variabi

265 Three dogs from each group were euthanized and tissue collected at 360 m

266 Four animals from each group were euthanized at 4 and 8 weeks postoperativ

267 Ten animals from each group were euthanized at 7, 15, and 30 days after t

268 tion between tumour size and SUVmax-T within each group were evaluated statistically.

269 121 (90%) patients in each group were included in the analysis of the primary

270 ce by five participants, 214 participants in each group were included in the intention-to-treat analy

271 Two patients in each group were lost to follow-up.

272 zanavir group (n=249); two participants from each group were randomised to treatment but did not rece

273 for the 2013-14 influenza season and half of each group were randomly allocated to free vaccines for

274 Patients in each group were randomly assigned (1:1) using a computer

275 The data assembled and analyzed by each group were reviewed by all authors and combined int

276 Mice from each group were sacrificed daily.

277 tive methods, and the top 181 compounds from each group were selected.

278 One-, 5-, and 10-year survivals in each group were similar (OPCAB vs CPB: 96.7%, 87.9%, 72.

279 Sixty eggs - randomly selected from each group - were analysed for physicochemical propertie

280 derwent randomization, the first 218 (109 in each group) were included in the primary intention-to-tr

281 Overall, 120 participants (60 in each group) were included, and 239 eyes were analyzed (1

282 p) and two serious violent incidents (one in each group) were noted, but no adverse events were deeme

283 A total of 1,248 children (624 randomized to each group) were recruited, and 1,096 (549 in the interv

284 In total, 1,248 children (624 randomized to each group) were recruited, and 1,096 (549 intervention,

285 A total of 252 blood cultures, 126 in each group, were included in the final analysis.

286 actions were mild, transient, and similar in each group, whereas none of the spontaneously reported a

287 glycated hemoglobin level was 7.5+/-1.2% in each group, whereas the mean fasting plasma glucose leve

288 en Met/Met, Met/Val, and Val/Val carriers in each group, which indicated that the BDNF Val66Met SNP d

289 sting; data was tabulated for only the 16 in each group who complied with their assigned intake frequ

290 We identified those individuals in each group who differed from the mean of the distributio

291 ompare markers in iron-deficient children in each group who received 28 d of iron supplementation dur

292 imary endpoint was proportion of patients in each group who were progression-free at 18 weeks.

293 CC groups) and at day 28 between children in each group who were randomly assigned to receive iron or

294 ample size was calculated as 35 patients for each group with a dropout rate of 10%.

295 y endpoint was the proportion of patients in each group with an mUFC concentration of less than or eq

296 ear wave elastography identified subjects in each group with significant fibrosis (Ishak score >/=3)

297 spatially distinct independent components in each group, with generation of local circuits increasing

298 caling and root planing (SRP) and placebo in each group, with minimum 10 participants and follow-up p

299 One participant from each group withdrew after consent, before intervention,

300 Subconjunctival injection for each group (XG-102 90 mug, XG-102 900 mug, or placebo) w